PRTN3 and rheumatoid arthritis: The existence of this novel mechanism of bone resorption could explain why bone destruction in RA progresses despite the absence or suppressed inflammation (in healthy anti-citrullinated protein antibody (ACPA)-positive individuals or patients achieving sustained clinical remission) and why the first bone lesions appear in the cortical bone, at the border of the joint and bone marrow [16,17].